# US 2020/0368326 A1 · Use of igf-1 in the preparation of medicaments for preventing and/or treating liver tumors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0368326 A1
- Document ID: US20200368326A1
- Status: Published application
- Kind: A1
- Application number: 16/877,907
- Filed: 2020-05-19
- Published: 2020-11-26
- Earliest claimed: 2019-05-20
- Assignees: Dalian Medical University
- Applicants: Dalian Medical University
- Inventors: Aiguo WANG; Jingyu WANG; Xu ZHENG; Xiaoqin LUO; Huiling LI
- Web page: https://patentgrep.com/patent/US20200368326A1

## CPC

- A61K 38/30: Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 {(insulin-like growth factor binding protein A61K38/1754)}
- A61P 35/00: Antineoplastic agents
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides a use of IGF-1 in the preparation of medicaments for preventing and/or treating liver tumors, relating to the technological field of prevention and treatment of hepatocarcinoma. In embodiments of the present invention, experiments are carried out on mice, demonstrating that over-expression of IGF-1 in hepatocytes induces the apoptosis of cancerous cells indirectly, and inhibits the occurrence and development of liver tumors; high level of IGF-1 significantly promotes the function of thymus, delays the degeneration of thymus, and does not cause the dysfunction of thymus; high level of IGF-1 significantly promotes the function of spleen T lymphocyte; high level of IGF-1 significantly enhances the number and activity of tumor infiltrating T lymphocytes; long-term over-expression of IGF-1 does not significantly promote the incidence of tumors in all organs and tissues in mice, indicating the safety of high IGF-1 level in the body.

## Claims

### Claim 1

A method for preventing and/or treating liver tumors with IGF-1, comprising improving the level of IGF-1 in the body.

### Claim 2 (depends on 1)

The method of claim 1, wherein the level of IGF-1 in the body is improved with exogenous IGF-1.

### Claim 3 (depends on 2)

The method of claim 2, wherein the exogenous IGF-1 is ingested by means of injection, gavage, swallowing or gene transfection techniques.

### Claim 4 (depends on 1)

The method of claim 1, wherein the prevention and/or treatment of liver tumors is achieved by promoting the function of thymus with IGF-1.

### Claim 5 (depends on 2)

The method of claim 2, wherein the prevention and/or treatment of liver tumors is achieved by promoting the function of thymus with IGF-1.

### Claim 6 (depends on 3)

The method of claim 3, wherein the prevention and/or treatment of liver tumors is achieved by promoting the function of thymus with IGF-1.

### Claim 7 (depends on 1)

The method of claim 1, wherein the prevention and/or treatment of liver tumors is achieved by promoting the function of spleen T lymphocytes with IGF-1.

### Claim 8 (depends on 2)

The method of claim 2, wherein the prevention and/or treatment of liver tumors is achieved by promoting the function of spleen T lymphocytes with IGF-1.

### Claim 9 (depends on 3)

The method of claim 3, wherein the prevention and/or treatment of liver tumors is achieved by promoting the function of spleen T lymphocytes with IGF-1.

### Claim 10

A medicament for preventing and/or treating liver tumors, comprising IGF-1 and excipients.
